| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/14/2005 | CA2551110A1 Treatment of cancer with novel anti-il 13 monoclonal antibodies |
| 07/14/2005 | CA2551097A1 Agonist anti-trkc antibodies and methods using same |
| 07/14/2005 | CA2551023A1 Maize metallothionein promoter |
| 07/14/2005 | CA2551008A1 Anti-cd40 antibody mutants |
| 07/14/2005 | CA2550998A1 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/14/2005 | CA2550996A1 Methods for generating multimeric molecules |
| 07/14/2005 | CA2550933A1 Methods for identifying functional antibodies |
| 07/14/2005 | CA2550927A1 A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
| 07/14/2005 | CA2550651A1 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | CA2550455A1 Haemophilus influenzae type iv pili |
| 07/14/2005 | CA2550356A1 Heh4 molecules and uses thereof |
| 07/14/2005 | CA2550316A1 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/14/2005 | CA2549652A1 Cd40 antibody formulation and methods |
| 07/14/2005 | CA2548947A1 Anti-cd52 antibody treatment for diabetes |
| 07/14/2005 | CA2548757A1 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | CA2548181A1 Anti-retroviral agents, compositions, methods and uses |
| 07/13/2005 | EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553179A1 Mouse-origin proteins forming domain or use thereof |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552848A1 Compositions against chicken coccidiosis |
| 07/13/2005 | EP1552462A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 07/13/2005 | EP1552310A2 Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| 07/13/2005 | EP1552300A2 Sets of digital antibodies directed against short epitopes, and methods using same |
| 07/13/2005 | EP1551994A2 Means of detecting neurodegenerative processes and applications of same |
| 07/13/2005 | EP1551990A2 Diagnosis and treatment of chemoresistant tumors |
| 07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 07/13/2005 | EP1551979A2 Compositions and methods for treatment and detection of multiple cancers |
| 07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/13/2005 | EP1551973A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551960A2 Hepatitis c viral-like particle purification |
| 07/13/2005 | EP1551957A2 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 07/13/2005 | EP1551955A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 07/13/2005 | EP1551877A2 Taci antibodies and uses thereof |
| 07/13/2005 | EP1551876A2 Antibodies that bind cell-associated ca 125/0722p and methods of use thereof |
| 07/13/2005 | EP1551875A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551453A2 Specificity grafting of a murine antibody onto a human framework |
| 07/13/2005 | EP1551452A1 Compositions and methods for therapeutic treatment |
| 07/13/2005 | EP1551450A1 Markers of blood barrier permeability and methods of using same |
| 07/13/2005 | EP1551448A2 Targeted cd1d molecules |
| 07/13/2005 | EP1551447A2 Anti-addl antibodies and uses thereof |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1021722B1 Improvements in or relating to screening for papilloma viruses |
| 07/13/2005 | EP0804548B1 Patched genes and their use |
| 07/13/2005 | EP0750512B1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639572A Assay for anti-INGAP antibodies |
| 07/13/2005 | CN1639195A Selective targeting of tumor vasculature using antibody molecules |
| 07/13/2005 | CN1639194A Antibodies against cancer |
| 07/13/2005 | CN1639193A Antibodies against fibroblast growth factor 23 |
| 07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
| 07/13/2005 | CN1639191A 鼠李糖结合蛋白 Rhamnose-binding protein |
| 07/13/2005 | CN1639185A Cancer-associated epitope |
| 07/13/2005 | CN1638807A Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 07/13/2005 | CN1638800A Human monoclonal antibodies against CD30 |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638798A Antibody-containing solution pharmaceuticals |
| 07/13/2005 | CN1638797A Cancer treatment |
| 07/13/2005 | CN1638796A Methods of administering anti-TNF alpha antibodies |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1637019A Vascular adhesion molecules and modulation of their function |
| 07/13/2005 | CN1210402C Broad-spectrum delta-enotoxins |
| 07/13/2005 | CN1210401C Compound from moraxella catarrhalis |
| 07/13/2005 | CN1210309C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 07/13/2005 | CN1210308C Humanized anti-HER2 monoclonal antibody, its preparation method and pharmaceutical composition thereof |
| 07/13/2005 | CN1210307C Humanized anti-CD 20 monoclonal antibody |
| 07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
| 07/12/2005 | US6916906 Protein mixture which confers vancomycin and teicoplanin resistance to bacteria; detecting antibiotic resistant enterococci, streptococci and staphylococci |
| 07/12/2005 | US6916903 Collagen type III synthetic peptides for collagen resorption assays |
| 07/12/2005 | US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/12/2005 | US6916644 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 07/12/2005 | US6916628 Method for the measurement of soluble CD14 proteins separately |
| 07/12/2005 | US6916627 ATM kinase compositions and methods |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916624 Antibody for use in the diagnosis and treatment of cancer |
| 07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 07/12/2005 | US6916607 Gene controlling androgen |
| 07/12/2005 | US6916605 Methods for producing members of specific binding pairs |
| 07/12/2005 | US6916604 Uses of synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites |
| 07/12/2005 | US6916477 Vaccine containing attenuated virus; induction antibodies; veterinary medicine |
| 07/12/2005 | US6916475 Anti-idiotypic antibody and its use in regulating the composition of T cell lymphocytes |
| 07/12/2005 | US6916474 Binds immunologically to bacillus anthracis protective antigen with an affinity kd of 140-21 pm determined by surface plasmon resonance |
| 07/12/2005 | US6916419 Contacting a sample in a flowable liquid state with a solid substrate comprised of a prion complexing agent; allowing the sample to remain in contact with the substrate for time such that prion in the sample bind to the substrate |
| 07/12/2005 | CA2303421C Beta-defensins |
| 07/12/2005 | CA2264275C Monoclonal antibody specific to an anti-human fibrin monomer, method for producing the monoclonal antibody, hybridoma, and immunoassay |
| 07/12/2005 | CA2201419C Human t-cell lymphotropic virus type i envelope protein and human monoclonal antibodies specific therefor |
| 07/12/2005 | CA1341485C Fusion proteins utilizing the decay accelerating factor membrane binding domain |
| 07/09/2005 | CA2452162A1 Diabetogenic epitope from a .alpha./.beta.-gliadin a-ii precursor, .alpha./.beta.-gliadin mm1 precursor or g1b1 |
| 07/07/2005 | WO2005061547A2 Bispecific antibodies |
| 07/07/2005 | WO2005061546A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 07/07/2005 | WO2005061545A2 Nogoa antibodies for the treatment of alzheimer disease |
| 07/07/2005 | WO2005061544A2 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 07/07/2005 | WO2005061543A1 Purification of immunoglobulins |
| 07/07/2005 | WO2005061542A2 Detection of cd20 in transplant rejection |
| 07/07/2005 | WO2005061541A1 Anti-igf-i receptor antibody |
| 07/07/2005 | WO2005061540A2 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 07/07/2005 | WO2005061482A1 Ecstasy haptens and immunogens |
| 07/07/2005 | WO2005061000A1 Remedy for angitis |